Home » Topics » BioWorld Science

BioWorld Science
RSS

M2-mAChRs as therapeutic targets for treating substance use disorders

July 28, 2022

IDP Discovery Pharma describes new VEGF inhibitors

July 28, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents G12C mutant GTPase KRAS inhibitors

July 28, 2022

New galectin-3 inhibitors synthesized at Galecto Biotech

July 28, 2022

Shionogi discovers 5-HT2A receptor antagonists and/or inverse agonists

July 28, 2022

Medshine Discovery identifies new CREBBP and/or p300 inhibitors

July 28, 2022

ZyVersa receives grant to assess potential of IC-100 to block neuroinflammation in Parkinson's

July 27, 2022

Vitamin B6 benzohydrazide platinum(II) complexes overcome cisplatin resistance in tumors

July 27, 2022

Amubarvimab/romlusevimab retains neutralizing activity against live Omicron subvariants

July 27, 2022

Monoclonal antibody pairs "zipper" to target cancer

July 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.